Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3

1(100.0%)

1Total

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT02477085Completed

Methods of Labor Induction and Perinatal Outcomes

Role: collaborator

NCT02751827Completed

Predicting Severe Toxicity of Targeted Therapies in Elderly Patients With Cancer

Role: collaborator

NCT03052985Active Not Recruiting

Materiovigilance After Urinary Incontinence or Prolapse Surgery

Role: collaborator

NCT03453411Completed

Effects of EMONO in Children During Dental Care

Role: collaborator

NCT02954679Completed

French Study on COgnitive Enhancement and Consumption of Psychoactive Substances Among Youth Students

Role: collaborator

NCT02794831Completed

Exposure to NSAIDs (Non Steroidal Anti-Inflammatory Drugs) and Severity of Community-acquired Bacterial Infections

Role: collaborator

NCT02502773Phase 3Completed

Fluid Loading in Abdominal Surgery: Saline Versus Hydroxyethyl Starch (FLASH Study)

Role: collaborator

All 7 trials loaded